Standard BioTools Inc. (LAB)

Standard BioTools Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	656	175	93	300	445	242
Market Cap Growth	409.95%	89.12%	-69.06%	-32.58%	83.70%	-28.58%
Enterprise Value	285	159	30	383	472	243
PE Ratio	-	-2.35	-0.49	-5.06	-8.39	-3.74
PS Ratio	5.17	1.65	0.95	2.30	3.22	2.07
PB Ratio	1.14	-1.18	-1.14	3.17	3.20	1.58
P/FCF Ratio	-7.87	-3.80	-1.00	-5.23	-15.81	-6.41
P/OCF Ratio	-8.08	-4.05	-1.04	-6.80	-28.85	-6.88
EV/Sales Ratio	2.25	1.49	0.30	2.93	3.41	2.08
EV/EBITDA Ratio	-5.44	-2.42	-0.16	-6.82	-10.60	-4.17
EV/EBIT Ratio	-4.82	-2.28	-0.16	-6.40	-9.33	-3.90
EV/FCF Ratio	-4.16	-3.44	-0.32	-6.68	-16.76	-6.45
Debt / Equity Ratio	0.16	-0.66	-1.26	1.18	0.69	0.39
Debt / EBITDA Ratio	-1.20	-1.50	-0.55	-1.99	-2.14	-1.03
Debt / FCF Ratio	-0.92	-2.13	-1.10	-1.95	-3.39	-1.59
Quick Ratio	4.14	1.23	4.21	0.94	1.73	2.36
Current Ratio	4.51	1.45	4.81	1.45	2.17	2.93
Asset Turnover	0.28	0.31	0.26	0.45	0.45	0.42
Interest Coverage	-24.99	-15.25	-43.55	-15.65	-14.15	-14.59
Return on Equity (ROE)	-295.40%	60.90%	476.60%	-55.60%	-37.50%	-38.60%
Return on Assets (ROA)	-30.30%	-21.50%	-50.10%	-20.60%	-17.40%	-23.40%
Return on Capital (ROIC)	-17.96%	153.69%	-548.45%	-32.71%	-21.77%	-24.27%
Earnings Yield	-20.74%	-42.55%	-204.90%	-19.76%	-11.92%	-26.76%
FCF Yield	-15.23%	-26.28%	-100.45%	-19.12%	-6.33%	-15.59%
Buyback Yield / Dilution	-271.93%	-1.09%	-3.32%	-5.19%	-7.88%	-68.41%
Total Shareholder Return	-271.93%	-1.09%	-3.32%	-5.19%	-7.88%	-68.41%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).